ARYx Therapeutics, Inc. (ARYX)
0.0000
0.00 (0.00%)
USD |
OTCM |
Jun 10, 16:00
ARYx Therapeutics Shareholders Equity (Quarterly)
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2010 | -7.735M |
| June 30, 2010 | -5.933M |
| March 31, 2010 | -2.404M |
| December 31, 2009 | -2.916M |
| September 30, 2009 | 1.816M |
| June 30, 2009 | 9.36M |
| March 31, 2009 | 18.01M |
| December 31, 2008 | 27.42M |
| Date | Value |
|---|---|
| September 30, 2008 | 19.04M |
| June 30, 2008 | 15.25M |
| March 31, 2008 | 26.57M |
| December 31, 2007 | 35.35M |
| September 30, 2007 | -1.63M |
| June 30, 2007 | |
| March 31, 2007 | |
| December 31, 2006 | -93.71M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| ANI Pharmaceuticals, Inc. | 562.30M |
| Corcept Therapeutics, Inc. | 637.99M |
| Assertio Holdings, Inc. | 75.63M |
| Veru, Inc. | 34.79M |
| Johnson & Johnson | 81.19B |